- Consumer Products
- Latest 1.47
- Currency C$
- Change 0.06
- Percent Change 4.255 %
- Volume 14,020
- Wed Dec 4, 2013 03:55 PM EST TSX data delayed 15 minutes.
12 months ended Apr 30, 2013.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Oct 30||n/a||Dec 9||n/a|
12 months ended Dec 04, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
HELIX BIOPHARMA CORP. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing products for the prevention and treatment of cancer. Helix's product development initiatives include Topical Interferon Alpha-2b and its new drug candidate L-DOS47 .